Compile Data Set for Download or QSAR
maximum 50k data
Found 2802 with Last Name = 'kluge' and Initial = 'af'
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642632(US20230416245, Compound 70)
Affinity DataKi:  0.133nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642621(US20230416245, Compound 59)
Affinity DataKi:  0.230nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642624(US20230416245, Compound 62)
Affinity DataKi:  0.330nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642626(US20230416245, Compound 64)
Affinity DataKi:  0.640nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642625(US20230416245, Compound 63)
Affinity DataKi:  0.720nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642618(US20230416245, Compound 45)
Affinity DataKi:  1.30nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642635(US20230416245, Compound 83)
Affinity DataKi:  1.62nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642631(US20230416245, Compound 69)
Affinity DataKi:  1.68nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642620(US20230416245, Compound 35)
Affinity DataKi:  1.70nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642615(US20230416245, Compound 40)
Affinity DataKi:  2nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642636(US20230416245, Compound 90)
Affinity DataKi:  2.42nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642639(US20230416245, Compound 93)
Affinity DataKi:  2.59nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642627(US20230416245, Compound 65)
Affinity DataKi:  3.49nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642630(US20230416245, Compound 68)
Affinity DataKi:  4.75nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642634(US20230416245, Compound 82)
Affinity DataKi:  4.77nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642637(US20230416245, Compound 91)
Affinity DataKi:  5.10nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBifunctional glutamate/proline--tRNA ligase(Homo sapiens (Human))
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50097096(2-(4-Bromo-phenyl)-6-chloro-8-methyl-quinoline-4-c...)
Affinity DataKi:  5.10nMAssay Description:Binding affinity towards 5-hydroxytryptamine 3 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642623(US20230416245, Compound 61)
Affinity DataKi:  7.15nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBifunctional glutamate/proline--tRNA ligase(Homo sapiens (Human))
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50097096(2-(4-Bromo-phenyl)-6-chloro-8-methyl-quinoline-4-c...)
Affinity DataKi:  15nMAssay Description:Binding affinity towards 5-hydroxytryptamine 3 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642619(US20230416245, Compound 46)
Affinity DataKi:  21.3nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642638(US20230416245, Compound 92)
Affinity DataKi:  26.8nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642617(US20230416245, Compound 44)
Affinity DataKi:  28.4nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642629(US20230416245, Compound 67)
Affinity DataKi:  94.4nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642628(US20230416245, Compound 66)
Affinity DataKi:  126nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642633(US20230416245, Compound 71)
Affinity DataKi:  456nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642622(US20230416245, Compound 60)
Affinity DataKi: >9.40E+3nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlatelet-derived growth factor receptor alpha(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM106562(US8586600, III-14)
Affinity DataIC50:  0.730nMAssay Description:Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogen...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPlatelet-derived growth factor receptor alpha(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM106560(US8586600, II-55)
Affinity DataIC50:  1.40nMAssay Description:Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogen...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075067(((S)-2-Amino-4-methyl-pentanoyl)-sulfamic acid (2R...)
Affinity DataIC50:  1.60nMAssay Description:Compound tested for the inhibition of E. coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075069(((S)-2-Amino-4-methyl-pentanoyl)-sulfamic acid (2R...)
Affinity DataIC50: <2nMAssay Description:Compound tested for the inhibition of E. coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor alpha(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM106553(US8586600, II-2)
Affinity DataIC50:  2.20nMAssay Description:Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogen...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProline--tRNA ligase, cytoplasmic(Candida albicans)
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50097096(2-(4-Bromo-phenyl)-6-chloro-8-methyl-quinoline-4-c...)
Affinity DataIC50:  5nMAssay Description:Aminoacylation activity against Candida albicans prolyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50128465((S)-2-{[1-((R)-2-Amino-3-mercapto-propionyl)-4-phe...)
Affinity DataIC50:  5nMAssay Description:Inhibition of Candida albicans Geranylgeranyl transferase type IMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM50128463((S)-2-{[1-((R)-2-Amino-3-mercapto-propionyl)-4-phe...)
Affinity DataIC50: <5nMAssay Description:Inhibition of Candida albicans Geranylgeranyl transferase type IMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor alpha(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM106561(US8586600, III-6)
Affinity DataIC50:  5.90nMAssay Description:Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogen...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Cubist Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075055(((S)-2-Amino-4-methyl-pentanoyl)-sulfamic acid (2R...)
Affinity DataIC50:  6nMAssay Description:Compound tested for the inhibition of human isoleucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlatelet-derived growth factor receptor alpha(Homo sapiens (Human))
Celgene Avilomics Research

US Patent
LigandPNGBDBM106565(US8586600, II-45)
Affinity DataIC50:  7.90nMAssay Description:Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogen...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397389(US10596172, Compound I-351 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397390(US10596172, Compound I-352 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397281(US10596172, Compound I-353 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397282(US10596172, Compound I-354 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397283(US10596172, Compound I-355 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397284(US10596172, Compound I-356 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397285(US10596172, Compound I-357 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397391(US10596172, Compound I-358 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397286(US10596172, Compound I-359 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM437958(US10596172, Compound I-360 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Celgene Car

US Patent
LigandPNGBDBM397287(US10596172, Compound I-362 | US10828300, Compound ...)
Affinity DataIC50: <10nMAssay Description:Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and ap...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
Kymera Therapeutics

US Patent
LigandPNGBDBM547691(US11292792, CMPD # I-2)
Affinity DataIC50: <10nMAssay Description:Equal volumes of His-tagged CRBN-DDB1 complex (56 nM) was mixed with Eu-cryptate labeled Anti-6HIS-monoclonal antibody (50× dilution from the commerc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
Kymera Therapeutics

US Patent
LigandPNGBDBM547693(US11292792, CMPD # I-5)
Affinity DataIC50: <10nMAssay Description:Equal volumes of His-tagged CRBN-DDB1 complex (56 nM) was mixed with Eu-cryptate labeled Anti-6HIS-monoclonal antibody (50× dilution from the commerc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 2802 total ) | Next | Last >>
Jump to: